Suresh Muthukumaraswamy
Associate Professor of Pharmacy at the University of Auckland
Data updated
Research Footprint
Suresh Muthukumaraswamy appears in 37 tracked papers (2013–2026), most studied alongside LSD, Ketamine and Psilocybin, across Healthy Volunteers, Neuroimaging & Brain Measures and Depressive Disorders.
Most-cited paper: Neural correlates of the LSD experience revealed by multimodal neuroimaging (875 citations).
Frequent co-authors: Robin Carhart-Harris, Rebecca Sumner and David Nutt.
Publication Landscape
How the 37 papers Blossom tracks for Suresh Muthukumaraswamy line up by year, topic, and journal. These are the psychedelic-relevant papers in Blossom's records as of July 2026, not a complete bibliography.
How has Suresh Muthukumaraswamy's publishing grown?
SourcedTracked papers by publication year. Click a year for the running total.
Don't read as total output: only the 37 of 37 tracked papers with a recorded publication date are counted, and these are the psychedelic-relevant papers Blossom tracks, not a complete bibliography. The current year is still filling in.
What does Suresh Muthukumaraswamy publish on?
SourcedTracked papers per topic. Orange marks the largest research focus.
Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Where does Suresh Muthukumaraswamy publish?
SourcedTracked papers per journal. Orange marks the most-used journal.
Counts the journal recorded on each tracked paper; preprints and papers with no journal on file are not shown. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Background & Research
Suresh Muthukumaraswamy is a neuro-psycho-pharmacologist specializing in how drugs modify brain activity. Using MEG, EEG, and fMRI, he has led pioneering work on the neural correlates of LSD, psilocybin, and ketamine. His current research at the University of Auckland investigates the effects of psychedelic microdosing on mood and neural plasticity in both healthy and clinical populations.
Key Impact
Expert in neuroimaging who produced the first images of the brain on LSD.
Collaboration Network
63 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Suresh Muthukumaraswamy's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.
Affiliations
Institutions, companies, and organisations Suresh Muthukumaraswamy is associated with.
University of Auckland
The University of Auckland hosts academic psychedelic research activity, including work led by Professor Suresh Muthukumaraswamy on LSD microdosing and related mental health applications.
View stakeholder →University of Wisconsin–Madison School of Pharmacy
The University of Wisconsin–Madison School of Pharmacy is the pharmacy school of the public research university UW–Madison, located in Madison, Wisconsin. It offers professional (PharmD), graduate and research programs in pharmaceutical sciences, clinical pharmacy, and related fields.
View stakeholder →